Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-long vs Long GnRH Agonist Protocol in Adenomyosis IVF
NCT03940807Phase 3Withdrawn
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Apr 2022
- Primary completion
- Jan 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in adenomyosis, sponsored by Centre hospitalier universitaire de Toulouse. Planned start Apr 2022; status: withdrawn.
02
Drugs
triptorelin
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT03940807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03940807.